272 related articles for article (PubMed ID: 25211508)
1. Pediatric brain tumor cell lines.
Xu J; Margol A; Asgharzadeh S; Erdreich-Epstein A
J Cell Biochem; 2015 Feb; 116(2):218-24. PubMed ID: 25211508
[TBL] [Abstract][Full Text] [Related]
2. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
3. Oncogene amplification in pediatric brain tumors.
Wasson JC; Saylors RL; Zeltzer P; Friedman HS; Bigner SH; Burger PC; Bigner DD; Look AT; Douglass EC; Brodeur GM
Cancer Res; 1990 May; 50(10):2987-90. PubMed ID: 2334901
[TBL] [Abstract][Full Text] [Related]
4. Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors.
Chakravadhanula M; Ozols VV; Hampton CN; Zhou L; Catchpoole D; Bhardwaj RD
Cancer Genet; 2014 Sep; 207(9):425-8. PubMed ID: 25085602
[TBL] [Abstract][Full Text] [Related]
5. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
6. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants.
Mapstone TB; Galloway PG
Pediatr Neurosurg; 1991-1992; 17(4):169-74. PubMed ID: 1668298
[TBL] [Abstract][Full Text] [Related]
7. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
8. Brain tumors: Medulloblastoma, ATRT, ependymoma.
Baliga S; Gandola L; Timmermann B; Gail H; Padovani L; Janssens GO; Yock TI
Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28395. PubMed ID: 32386126
[TBL] [Abstract][Full Text] [Related]
9. [Progress of molecular pathology in pediatric brain tumor].
WANG YJ; PIAO YS; LU DH
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):206-8. PubMed ID: 21575401
[No Abstract] [Full Text] [Related]
10. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
[TBL] [Abstract][Full Text] [Related]
12. The role of stem cells in pediatric central nervous system malignancies.
Manoranjan B; Garg N; Bakhshinyan D; Singh SK
Adv Exp Med Biol; 2015; 853():49-68. PubMed ID: 25895707
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Brain Tumors: An Update.
Segal D; Karajannis MA
Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):242-250. PubMed ID: 27230809
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors.
Ogino S; Kubo S; Abdul-Karim FW; Cohen ML
Pediatr Dev Pathol; 2001; 4(1):23-31. PubMed ID: 11200487
[TBL] [Abstract][Full Text] [Related]
15. Myc proteins in brain tumor development and maintenance.
Swartling FJ
Ups J Med Sci; 2012 May; 117(2):122-31. PubMed ID: 22348395
[TBL] [Abstract][Full Text] [Related]
16. Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor.
Kleinschmidt-DeMasters BK; Lovell MA; Donson AM; Wilkinson CC; Madden JR; Addo-Yobo SO; Lillehei KO; Foreman NK
Acta Neuropathol; 2007 Jun; 113(6):695-703. PubMed ID: 17431644
[TBL] [Abstract][Full Text] [Related]
17. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas.
Yamashita Y; Kumabe T; Higano S; Watanabe M; Tominaga T
Neurol Res; 2009 Nov; 31(9):940-6. PubMed ID: 19138469
[TBL] [Abstract][Full Text] [Related]
18. Mapping pediatric brain tumors to their origins in the developing cerebellum.
Okonechnikov K; Joshi P; Sepp M; Leiss K; Sarropoulos I; Murat F; Sill M; Beck P; Chan KC; Korshunov A; Sah F; Deng MY; Sturm D; DeSisto J; Donson AM; Foreman NK; Green AL; Robinson G; Orr BA; Gao Q; Darrow E; Hadley JL; Northcott PA; Gojo J; Kawauchi D; Hovestadt V; Filbin MG; von Deimling A; Zuckermann M; Pajtler KW; Kool M; Jones DTW; Jäger N; Kutscher LM; Kaessmann H; Pfister SM
Neuro Oncol; 2023 Oct; 25(10):1895-1909. PubMed ID: 37534924
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic histopathology, cytogenetics, and molecular markers of pediatric brain tumors.
Schofield DE
Neurosurg Clin N Am; 1992 Oct; 3(4):723-38. PubMed ID: 1327339
[TBL] [Abstract][Full Text] [Related]
20. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
